Integrative and Computational Biology Joint symposium

Barcelona 27-28 March 2014


Program

Thursday 27 March

08.50 - 09.00

Welcome from the Organizers

09.00-10.50

Session 1: Big Biological DatasetsChair: Ben Lehner

09.00-09.30

Luis Serrano

Centre for Genomic Regulation (CRG), Spain
Protein competition as a means for cell specific signaling
 

09.30-10.00

Olga Troyanskaya

Lewis-Sigler Institute for Integrative Genomics
A tissue-specific view of human disease from integrated data analysis

10.00-10.30

Roderic Guigo

Centre for Genomic Regulation, Spain
RNA Heterogeneity in the eurkaryotic cell

10.30-10.50

Eduard Eyras

Pompeu Fabra University
The landscape of alternative splicing alterations in cancer

10.50 - 11.20

Coffee and Poster Session

11.20-13.30

Session 2: Modelling ChromatinChair: Marc Martí-Renom

11.20-11.50

Modesto Orozco

Institute for Research in Biomedicine (IRB Barcelona), University of Barcelona (UB) and Barcelona Supercomputing Center (BSC), Spain
Chromatin analyzed with the eyes of physics

11.50-12.10

Luca Giorgetti

Invited Short Talk Speaker
Institute Curie, France
Predictive polymer modeling reveals coupled fluctuations in chromosome conformation and transcription

12.10-12.30

Ana M. Rojas

Institute of Biomedicine of Seville (IBIS), Spain
Emergence and conservation of DNA Damage Response proteins affecting chromatin remodelling

12.30-12.50

Vladimir Teif

German Cancer Research Center (DKFZ)
Nucleosome re-arrangement as a feedback mechanism between DNA methylation and transcription factor binding

12.50-13.30

Fast Track Session I: 8 Speed Talks

Speed presentations by selected poster authors

13.30-14-45

Lunch and Poster Session

Lunch and Poster Session

14.45-16.05

Session 3: Cancer Genomics (Part I)Chair: Sergio Alonso

14.45-15.35

Fast Track Session II: 9 Speed Talks

Speed presentations by selected poster authors

15.35-16.05

Nuria Lopez-Bigas

ICREA and Pompeu Fabra University, Spain
Identification of cancer drivers across tumor types

16.05-16.35

Alfonso Valencia

Spanish National Cancer Research Centre (CNIO), Spain
Analysis of Genomes and Cancer Genomes from an Evolutionary Perspective

16.35-17.05

Coffee and Poster Session

Coffee and Poster Session

17.05-19.00

Session 4: Cancer Genomics (part II)Chair: Alfonso Valencia

17.05-17.35

Niko Beerenwinkel

Swiss Federal Institute of Technology Zurich, Switzerland
Modeling cancer evolution from genomic data

17.35-18.05

Elizabeth Murchison

Wellcome Trust Sanger Institute, UK
Genetics and evolution of clonally transmissible cancers in dogs and Tasmanian devils

18.05.19.00

Søren Brunak EMBO KEYNOTE LECTURE

Center for Biological Sequence Analysis, Technical University of Denmark
Comorbidities and disease trajectories in cancer and beyond

19.00-20.00

Posters and Networking Session

Friday 28 March

09.30 - 11.30

Session 5: Regulatory GenomicsChair: Eduardo Eyras

09.30-10.00

Anne-Ferguson-Smith

University of Cambridge
Environmental modulation of epigenetic states in the sperm methylome and their consequences

10.00-10.20

Tanya Vavouri

Institute of Predictive and Personalized Medicine of Cancer (IMPPC)
The small RNA content of human sperm

10.20-10.50

Mihaela Zavolan

Biozentrum, University of Basel, Switzerland
Decoding miRNA-based regulation with low and high-throughput data

10.50-11.10

Lorenzo Pasquali

IDIBAPS
Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants

11.10-11.30

Tuncay Baubec

Friedrich Miescher Institute for Biomedical Research
DNA methylation: (epi-)genomic views on pattern generation and interpretation

11.30-12.00

Coffee

12.00 - 13.30

Session 6: Integrative BiologyChair: Olga Troyanskaya

12.00-12.30

Ewan Birney

EMBL-EBI, Wellcome Trust Genome Campus, UK
EMBL-EBI and Elixir: A life science infrastructure

12.30-13.00

Eileen Furlong

EMBL Heidelberg, Germany
cis-regulatory control during development

13.00-13.30

Nick Luscombe

University College London and Cancer Research UK London Research Institute (joint appointments)
Guardians of the transcriptome: how hnRNP C protects you from unwanted exons

13.30

Closing Remarks